The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Phase of Trial: Phase III
Latest Information Update: 13 Jun 2018
At a glance
- Drugs Bimatoprost (Primary) ; Timolol
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Allergan
- 13 Jun 2018 According to an Allergan media release, data from this study will be reported in the first half of 2019.
- 07 Feb 2018 Planned primary completion date changed from 4 Apr 2019 to 19 Mar 2019.
- 03 Jul 2017 Planned End Date changed from 1 Jul 2018 to 20 Aug 2020.